Phase 2 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast trials recruiting now

All Human Epidermal Growth Factor 2 Negative Carcinoma of Breast trials, every phase

Phase 2 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast trials

• Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
  NCT06348134 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 4 locations
• Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
  NCT05735080 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
  NCT07222215 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.